Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
- 1 May 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Nephrology and Hypertension
- Vol. 15 (3), 314-320
- https://doi.org/10.1097/01.mnh.0000222701.22583.e8
Abstract
This review summarizes current knowledge on asymmetric dimethylarginine, renal function in health and disease, and renal disease progression and examines interventions that may modify the plasma concentration of this methylarginine. Nitric oxide deficiency may occur in patients with chronic kidney disease and may contribute to accelerate progression of chronic kidney disease, hypertension and cardiovascular complications. An increase of endogenous nitric oxide inhibitors like asymmetric dimethylarginine seems to play a major role in this process. The kidneys are crucial in both, in re-absorbing and generating L-arginine as well as in eliminating asymmetric dimethylarginine primarily by the enzyme dimethylarginine dimethylaminohydrolase and to a minor degree by urinary excretion. Asymmetric dimethylarginine accumulation predicts both accelerated renal function loss and death in patients with chronic kidney disease and incident cardiovascular complications in patients with end stage renal disease. Asymmetric dimethylarginine is a new risk factor potentially implicated in the progression of renal insufficiency and in the high rate of cardiovascular complications of patients with chronic kidney disease.Keywords
This publication has 97 references indexed in Scilit:
- Recent Advances in the Regulation of Nitric Oxide in the KidneyHypertension, 2005
- Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl l -Arginine Accelerates Endothelial Cell SenescenceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertensionAmerican Heart Journal, 2004
- Redox regulation of the afferent arteriole and tubuloglomerular feedbackActa Physiologica Scandinavica, 2003
- Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney diseaseKidney International, 2003
- Effects of renin–angiotensin system blockade in the aging kidneyExperimental Gerontology, 2003
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- Aging Progressively Impairs Endothelium-Dependent Vasodilation in Forearm Resistance Vessels of HumansHypertension, 1996
- Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with agingLife Sciences, 1994
- Salt sensitivity in humans is associated with abnormal acid-base regulation.Hypertension, 1990